Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
Wu
Chia-Jen
CJ
Peng
Yi-Jen
YJ
Yu
Mu-Hsien
MH
Chen
Chi-Huang
CH
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D018269:Carcinoma, Endometrioid / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D005260:Female; D006801:Humans; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D017698:Postmenopause; D013629:Tamoxifen / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen